公司資料
Verastem, Inc. 股價、新聞與催化劑
- 股票代碼:
- VSTM
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
6.86 USD (-0.44%)
收盤價
最後更新: 2026年8月24日
335M USD
市值
股價為何變動
As of Aug 24, 2026, VSTM closed down 0.44% at $6.86. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Verastem is a biotechnology company focused on oncology and rare-disease pathways, including targeted cancer programs. Its story has centered on developing therapies for difficult-to-treat tumors.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Verastem sits in specialty oncology biotechnology.
商業模式特徵
The business depends on clinical validation, product development, and the ability to create a focused cancer franchise.
生技產業定位
Verastem is a catalyst-driven oncology name whose stock reacts to development and strategic milestones.
未來催化劑
- Verastem’s catalysts are avutometinib / defactinib and the ovarian-cancer / RAF-pathway development path. Investors will watch whether the combination story can keep building a credible oncology franchise.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。